I agree. The potential looked good here but my gut was to sell last week after the ongoing delay of assay results. There are countless examples of this kind of price action and delayed anns across the asx micro cap land. 9/10 times if the drill cores on the ground are decent or exceptional they pay a premium for a quick turnaround. Management and other holders capitalized on retail hopium to play their games here. The visuals and then the later release of the tables was the canary in the coal mine and that was demonstrated by the sell off at that time.
The price rise last few weeks were just traders speculating on results being released and if anything decent was actually in the pipeline I'm sure we would've seen the price get above 26c and move upwards until a probable sell the news event if the results were anything other than exceptional. I suspect those selling into the mid twenties had a some idea the results would be crap and hence killed the momentum of trader speculation.
- Forums
- ASX - By Stock
- SLM
- Ann: Assays Show Potential for Large Copper Mineralised System
Ann: Assays Show Potential for Large Copper Mineralised System, page-17
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.0¢ |
Change
0.004(4.65%) |
Mkt cap ! $6.961M |
Open | High | Low | Value | Volume |
8.7¢ | 9.1¢ | 8.7¢ | $4.775K | 53.09K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 20980 | 9.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.6¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 20980 | 0.090 |
1 | 8799 | 0.087 |
2 | 16243 | 0.086 |
1 | 125000 | 0.082 |
1 | 20000 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.096 | 50000 | 1 |
0.100 | 134468 | 2 |
0.110 | 15933 | 1 |
0.120 | 50000 | 1 |
0.125 | 12889 | 2 |
Last trade - 15.32pm 12/11/2024 (20 minute delay) ? |
Featured News
SLM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online